Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

207 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.
Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD. Kahn RS, et al. Among authors: westenberg hg. Int Clin Psychopharmacol. 1987 Jan;2(1):33-45. doi: 10.1097/00004850-198701000-00003. Int Clin Psychopharmacol. 1987. PMID: 3312397 Clinical Trial.
Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating.
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Oranje B, et al. Among authors: westenberg hg. J Psychopharmacol. 2004 Sep;18(3):388-94. doi: 10.1177/026988110401800310. J Psychopharmacol. 2004. PMID: 15358983 Clinical Trial.
No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Oranje B, et al. Among authors: westenberg hg. J Psychopharmacol. 2006 Nov;20(6):789-98. doi: 10.1177/0269881106061712. Epub 2006 Feb 14. J Psychopharmacol. 2006. PMID: 16478755 Clinical Trial.
d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.
de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. de Leeuw AS, et al. Among authors: westenberg hg. Eur Psychiatry. 2017 Feb;40:38-44. doi: 10.1016/j.eurpsy.2016.06.011. Epub 2016 Nov 10. Eur Psychiatry. 2017. PMID: 27837671 Clinical Trial.
Perception of facial expressions in obsessive-compulsive disorder: a dimensional approach.
Montagne B, de Geus F, Kessels RP, Denys D, de Haan EH, Westenberg HG. Montagne B, et al. Among authors: westenberg hg. Eur Psychiatry. 2008 Jan;23(1):26-8. doi: 10.1016/j.eurpsy.2007.07.007. Epub 2007 Oct 15. Eur Psychiatry. 2008. PMID: 17937980
Mirtazapine in social anxiety disorder: a pilot study.
Van Veen JF, Van Vliet IM, Westenberg HG. Van Veen JF, et al. Among authors: westenberg hg. Int Clin Psychopharmacol. 2002 Nov;17(6):315-7. doi: 10.1097/00004850-200211000-00008. Int Clin Psychopharmacol. 2002. PMID: 12409686 Clinical Trial.
Serotonergic compounds in panic disorder, obsessive-compulsive disorder and anxious depression: A concise review.
Den Boer JA, Westenberg HGM. Den Boer JA, et al. Among authors: westenberg hgm. Hum Psychopharmacol. 1995 Oct;10 Suppl 3(S3):S173-S183. doi: 10.1002/hup.470100906. Hum Psychopharmacol. 1995. PMID: 29569409
Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls.
Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG. Van Veen JF, et al. Among authors: westenberg hg. Eur Neuropsychopharmacol. 2007 Oct;17(10):637-42. doi: 10.1016/j.euroneuro.2007.03.005. Epub 2007 May 3. Eur Neuropsychopharmacol. 2007. PMID: 17481859 Clinical Trial.
Tolerability and safety of fluvoxamine and other antidepressants.
Westenberg HG, Sandner C. Westenberg HG, et al. Int J Clin Pract. 2006 Apr;60(4):482-91. doi: 10.1111/j.1368-5031.2006.00865.x. Int J Clin Pract. 2006. PMID: 16620364 Free PMC article. Review.
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.
Schutters SI, Van Megen HJ, Van Veen JF, Denys DA, Westenberg HG. Schutters SI, et al. Among authors: westenberg hg. Int Clin Psychopharmacol. 2010 Sep;25(5):302-4. doi: 10.1097/yic.0b013e32833a4d71. Int Clin Psychopharmacol. 2010. PMID: 20715300 Clinical Trial.
207 results
Jump to page
Feedback